Key result
Septal myectomy remains the gold standard for drug-refractory obstructive HCM, guided by multimodality imaging.
Why the study?
The role of multimodality imaging in preoperative planning and the place of surgery in obstructive HCM treatment amid the rise of myosin inhibitors needed evaluation.
Septal myectomy, guided by detailed multimodality imaging, remains the definitive treatment for symptomatic obstructive HCM refractory to medical therapy, even in the era of novel myosin inhibitors.
Answers are grounded in this paper and cite their sources.
Supports imaging-guided myectomy in refractory obstructive HCM; leaves open comparative trials versus myosin inhibitors in complex anatomy.
Aim. To evaluate modern approaches to preoperative planning of septal myectomy in patients with obstructive hypertrophic cardiomyopathy (HCM), to define the role of multimodality imaging (echocardiography, magnetic resonance imaging (MRI), computed tomography (CT)) and the place of surgical treatment in the era of rapid development and clinical implementation of selective myosin inhibitors. Materials and methods. An analytical review of current clinical guidelines, results of major clinical trials on myosin inhibitors, and fundamental publications on the principles of radiological planning and surgical techniques in obstructive HCM was performed. A literature search was conducted in PubMed, Scopus, and Google Scholar databases with the following keywords: hypertrophic cardiomyopathy, septal myectomy, preoperative planning, cardiac CT, cardiac MRI, myosin inhibitors. Results. Modern multimodality imaging represents an essential stage of preoperative assessment, providing the surgeon with the ability to optimally plan the extent of resection, minimize cardiopulmonary bypass time, and significantly reduce postoperative complications. Although myosin inhibitors demonstrate a marked reduction in left ventricular outflow tract gradients and improvement in clinical status – the complex morphological nature of obstruction, involving papillary muscles, subvalvular structures of the mitral valve, and systolic anterior motion of the anterior leaflet of the mitral valve – often limits the possibility of complete correction by medical therapy alone. Conclusions. Septal myectomy, when performed in highly specialized expert centers, remains the gold standard for patients with symptomatic obstructive HCM refractory to optimal medical therapy. The success and safety of this intervention are directly correlated with the precision and detail of preoperative planning, based on the modern cardiac imaging arsenal.
No takes yet. Share an insight, caveat, or question.
Tregubova et al. (2026) conducted a review in Obstructive hypertrophic cardiomyopathy. Septal myectomy, multimodality imaging, and myosin inhibitors was evaluated. Septal myectomy remains the gold standard for symptomatic obstructive hypertrophic cardiomyopathy refractory to medical therapy, with success relying on precise multimodality imaging planning.
Synapse has enriched 10 related papers. Consider them for comparative context: